Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).:
SEC Accession No. 0001370368-25-000006
Filing Date
2025-01-31
Accepted
2025-01-31 07:12:21
Documents
3

Document Format Files

Seq Description Document Type Size
1 IRANNOTICE a250131iran.htm IRANNOTICE 8434
2 letter-head.jpg GRAPHIC 18476
3 logo.jpg GRAPHIC 26773
  Complete submission text file 0001370368-25-000006.txt   71356
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: IRANNOTICE | Act: 34 | File No.: 001-15024 | Film No.: 25575907
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)